174 related articles for article (PubMed ID: 20012624)
1. Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control study.
van Bommel EF; van Tits LJ; van den Berg EA; Prins J; Stalenhoef AF
Rheumatol Int; 2011 Feb; 31(2):201-8. PubMed ID: 20012624
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to OxLDL are decreased in individuals with borderline hypertension.
Wu R; de Faire U; Lemne C; Witztum JL; Frostegård J
Hypertension; 1999 Jan; 33(1):53-9. PubMed ID: 9931081
[TBL] [Abstract][Full Text] [Related]
3. Circulating oxidized low-density lipoprotein is increased in hypertension.
Frostegård J; Wu R; Lemne C; Thulin T; Witztum JL; de Faire U
Clin Sci (Lond); 2003 Nov; 105(5):615-20. PubMed ID: 12837127
[TBL] [Abstract][Full Text] [Related]
4. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
Tsimikas S; Brilakis ES; Lennon RJ; Miller ER; Witztum JL; McConnell JP; Kornman KS; Berger PB
J Lipid Res; 2007 Feb; 48(2):425-33. PubMed ID: 17093289
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
[TBL] [Abstract][Full Text] [Related]
8. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
9. Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
Choi SH; Chae A; Miller E; Messig M; Ntanios F; DeMaria AN; Nissen SE; Witztum JL; Tsimikas S
J Am Coll Cardiol; 2008 Jul; 52(1):24-32. PubMed ID: 18582631
[TBL] [Abstract][Full Text] [Related]
10. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.
Su J; Georgiades A; Wu R; Thulin T; de Faire U; Frostegård J
Atherosclerosis; 2006 Sep; 188(1):160-6. PubMed ID: 16307748
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis.
Parums DV; Brown DL; Mitchinson MJ
Arch Pathol Lab Med; 1990 Apr; 114(4):383-7. PubMed ID: 2322097
[TBL] [Abstract][Full Text] [Related]
12. Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.
Vuilleumier N; Bratt J; Alizadeh R; Jogestrand T; Hafström I; Frostegård J
Scand J Rheumatol; 2010 Nov; 39(6):447-53. PubMed ID: 20604674
[TBL] [Abstract][Full Text] [Related]
13. Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.
Prasad A; Clopton P; Ayers C; Khera A; de Lemos JA; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1213-1221. PubMed ID: 28473443
[TBL] [Abstract][Full Text] [Related]
14. Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection.
Yilmaz A; Jennbacken K; Fogelstrand L
BMC Infect Dis; 2014 Mar; 14():143. PubMed ID: 24636004
[TBL] [Abstract][Full Text] [Related]
15. Obesity modulates the immune response to oxidized LDL in hypertensive patients.
Fonseca HA; Fonseca FA; Monteiro AM; Bianco HT; Boschcov P; Brandão SA; Juliano L; Gidlund M; Izar MC
Cell Biochem Biophys; 2013; 67(3):1451-60. PubMed ID: 23559274
[TBL] [Abstract][Full Text] [Related]
16. Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease.
Eichinger S; Kyrle PA; Kammer M; Eischer L; Ozsvar Kozma M; Binder CJ
J Thromb Haemost; 2018 Jan; 16(1):31-35. PubMed ID: 29045005
[TBL] [Abstract][Full Text] [Related]
17. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
[TBL] [Abstract][Full Text] [Related]
18. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
Lopez LR; Hurley BL; Simpson DF; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
[TBL] [Abstract][Full Text] [Related]
20. Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study.
Su J; Hua X; Vikström M; Leander K; Gigante B; Hellenius ML; de Faire U; Frostegård J
BMC Cardiovasc Disord; 2013 Jan; 13():1. PubMed ID: 23294904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
